Financial Gravity Asset Management, Inc. Gilead Sciences, Inc. Transaction History
Financial Gravity Asset Management, Inc.
- $506 Billion
- Q3 2025
A detailed history of Financial Gravity Asset Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 10 shares of GILD stock, worth $1,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 1,478
99.32%
Holding current value
$1,240
Previous $166 Million
99.33%
% of portfolio
0.0%
Previous 0.04%
Shares
27 transactions
Others Institutions Holding GILD
# of Institutions
2,372Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...